Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Emalex Biosciences
Emalex Biosciences
Emalex Biosciences reports data from Tourette syndrome therapy trial
Clinical Trials Arena
Thu, 01/12/23 - 10:37 am
Emalex Biosciences
clinical trials
Tourette syndrome
ecopipam
This biotech founder has a new plan to treat Tourette Syndrome, which affects 200,000 Americans each year
Business Insider
Wed, 01/4/23 - 09:31 am
Emalex Biosciences
Tourette syndrome
A Chicago biotech skips the IPO in favor of late-stage Series D for a PhIII Tourette drug
Endpoints
Thu, 11/3/22 - 10:58 am
Emalex Biosciences
funding
Tourette syndrome